Context

Founded in 2005, Woonzorgnet B.V. provides a broad range of psychiatric care.

There is a growing health market in the Netherlands, and in 2017 alone, health expenditure reached EUR 4.5k on average per capita vs EUR 3.3k for the countries within the OECD.

Reflecting this market dynamic and as part of their growth strategy, Woonzorgnet’s management realized that they needed to find a strategic partner to speed up development in the Netherlands.

About ORPEA

Since its creation in 1989, ORPEA has expanded rapidly to become one of the world leaders in long term care, with its network of 855 facilities, with 86,757 beds across 13 countries (13,659 of them under construction or redevelopment), including 32,582 beds in France (2,223 beds under construction or redevelopment) at 347 facilities, 54,175 beds outside France (Austria, Belgium, Brazil, China, Czech Republic, Germany, Italy, Netherlands, Poland, Portugal, Spain, and Switzerland) at 508 facilities. (11,436 beds under construction or redevelopment) ORPEA is listed on Euronext Paris and a constituent of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.

Discover ORPEA

About Woonzorgnet

Based in Renkum, the Hinterlands, Woonzorgnet offers sheltered housing, daycare and outpatient support for patients with mental health issues or psychiatric illnesses. The company operates seven facilities with 162 beds.

Discover Woonzorgnet

Philippe Patricot

Managing Director I Paris

Investment Banking

Wilem Bensaid

Vice President I Paris

Investment Banking

Deal Team

Should you want to know more about this transaction, you can contact one of the team members above

Bryan, Garnier & Co advises ORPEA Group on the acquisition of Woonzorgnet B.V. in the Netherlands

Bryan, Garnier & Co acted as the Sole Financial Advisor to ORPEA.

Bryan, Garnier & Co identified the target and negotiated the transaction with the selling shareholders.

The acquisition allows ORPEA to enter the very promising Dutch market thereby complementing its existing strong footprint in Continental Europe.

The transaction demonstrates the growth of Bryan, Garnier & Co’s work in the social care industries and the development of our footprint in the Netherlands such as the sale of Regas (a SaaS software vendor dedicated to health and social care industries) to BID Equity.